GTC Biotherapeutics (fka GTCB)

[ThomasS]

It's the java, folks... sorry. Another permutation:
"If" a partner were able to breakout HD revs from AD revs,
GTC grants the partner 100% of HD revs in exchange for all AD funding (which includes more than DIC, folks) and a larger than normal royalty on future AD revenues. This, again, mitigates partner risk and garners GTC greater revenues in the long haul. Since GTC has other fires smoldering, they might be able to swing such an arrangement with less near-term revs in exchange for greater later.

"If not," GTC grants the partner 100% of ATRYN revs for the first 2 years and then grabs an inordinate share of the future revs.

The converse could also work: GTC gets all revs for ATRYN USA for 3 years (to fund other internal programs and be in a stronger future partnering position) and then gets a lesser than normal royalty on total ATRYN sales.

The possibilities are numerous and may not follow conventional thought. I'll cease boring you folks for today. Only...